Cronos Group (CRON) Competitors $2.08 +0.04 (+1.96%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$2.07 -0.01 (-0.48%) As of 08:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRON vs. ACB, CGC, OGI, SNDL, TLRY, MOR, KYMR, ALVO, IMVT, and CRNXShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), MorphoSys (MOR), Kymera Therapeutics (KYMR), Alvotech (ALVO), Immunovant (IMVT), and Crinetics Pharmaceuticals (CRNX). These companies are all part of the "medical" sector. Cronos Group vs. Its Competitors Aurora Cannabis Canopy Growth Organigram Global SNDL Tilray Brands MorphoSys Kymera Therapeutics Alvotech Immunovant Crinetics Pharmaceuticals Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Which has higher earnings & valuation, ACB or CRON? Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.04$1.63M$0.1141.45Cronos Group$117.61M6.82$41.08M$0.1316.00 Do institutionals & insiders have more ownership in ACB or CRON? 47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 6.9% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer ACB or CRON? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ACB or CRON more profitable? Cronos Group has a net margin of 39.69% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis1.32% 0.13% 0.10% Cronos Group 39.69%-0.07%-0.07% Does the media prefer ACB or CRON? In the previous week, Aurora Cannabis had 1 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for Aurora Cannabis and 2 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.57 beat Aurora Cannabis' score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, ACB or CRON? Aurora Cannabis has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. SummaryAurora Cannabis beats Cronos Group on 10 of the 16 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$786.79M$2.68B$5.50B$8.95BDividend YieldN/A1.79%5.25%4.04%P/E Ratio16.008.9826.9720.11Price / Sales6.82714.59425.92119.81Price / Cash4,384.08159.8036.8257.86Price / Book0.724.517.985.56Net Income$41.08M$31.26M$3.16B$248.40M7 Day Performance4.00%3.57%2.36%4.67%1 Month Performance6.12%1.28%2.15%6.64%1 Year Performance-7.14%1.08%33.78%21.31% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group2.0494 of 5 stars$2.08+2.0%N/A-7.6%$786.79M$117.61M16.00450News CoverageACBAurora Cannabis0.0983 of 5 stars$4.24+2.2%N/A-7.9%$238.33M$246.72M38.551,130CGCCanopy Growth0.6793 of 5 stars$1.22flat$2.00+63.9%-80.4%$224.32M$225.65M-0.303,150News CoverageOGIOrganigram Global0.9599 of 5 stars$1.35flatN/A-8.9%$180.82M$117.47M13.50860News CoverageGap DownSNDLSNDL3.513 of 5 stars$1.21-1.6%$3.63+199.6%-29.9%$317.96M$671.81M-4.172,516TLRYTilray Brands2.1373 of 5 stars$0.41+3.4%$1.92+362.5%-66.2%$417.09M$210.48M-0.392,650MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730KYMRKymera Therapeutics3.1715 of 5 stars$43.64-1.1%$59.61+36.6%+35.9%$2.84B$47.07M-14.08170ALVOAlvotech3.9995 of 5 stars$9.12-0.2%$18.00+97.4%-27.5%$2.75B$491.98M24.651,032IMVTImmunovant1.3922 of 5 stars$16.00-0.6%$38.33+139.6%-38.9%$2.73BN/A-5.84120CRNXCrinetics Pharmaceuticals3.1512 of 5 stars$28.76-4.0%$74.56+159.2%-35.3%$2.69B$1.04M-7.53210 Related Companies and Tools Related Companies ACB Alternatives CGC Alternatives OGI Alternatives SNDL Alternatives TLRY Alternatives MOR Alternatives KYMR Alternatives ALVO Alternatives IMVT Alternatives CRNX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRON) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRON Stock Alerts